Medicine and Dentistry
Pancreas Islet Cell Tumor
100%
Surgery
84%
Neoplasm
55%
Distal Pancreatectomy
53%
Neuroendocrine Tumor
40%
Recurrent Disease
37%
Pancreaticoduodenectomy
34%
Liver Metastasis
24%
Pancreas Cancer
23%
Health Care Cost
22%
Splenectomy
21%
Cohort Analysis
19%
Multiple Endocrine Neoplasia Type I
19%
Reconstructive Surgery
19%
Clinical Feature
19%
Capecitabine
19%
Tail
19%
Temozolomide
19%
Hernioplasty
19%
Primary Hyperaldosteronism
19%
Myoelectricity
19%
Gastrointestinal Stromal Tumor
19%
Laparoscopic Cholecystectomy
19%
Umbilical Hernia
19%
Bile Duct Injury
19%
Neuroendocrine Carcinoma
19%
Liver Dysfunction
19%
Surgery
19%
Acute Lymphocytic Leukemia
19%
Pancreatectomy
18%
Operation Duration
15%
Overall Survival
14%
Disease Free Survival
14%
Progression Free Survival
14%
Stomach Paresis
14%
Enhanced Recovery After Surgery
14%
Laparoscopy
12%
Somatostatin Derivative
10%
Disease Specific Survival
9%
Lymph Node
9%
Recurrence Risk
9%
Multiple Endocrine Neoplasia
8%
Fistula
8%
Pancreas Adenocarcinoma
8%
Disease
8%
Subgroup Analysis
7%
Hepatectomy
7%
Mortality Rate
7%
Cancer Registry
7%
Bleeding
7%
Keyphrases
Transgastric Necrosectomy
38%
Metastatic Pancreatic Neuroendocrine Tumour
22%
Umbilical Hernia Repair
19%
Advanced or Metastatic
19%
Wound Healing
19%
Capecitabine
19%
Neoadjuvant
19%
Temozolomide
19%
Grade 3 Neuroendocrine Tumors
19%
Gastric Myoelectric Activity
19%
Ileal Neuroendocrine Tumors
19%
Primary Aldosteronism
19%
Liver Dysfunction
19%
Locally Advanced
19%
Interleukin-1 Signaling
19%
American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP)
19%
Propensity Score Analysis
19%
Interleukin
19%
Minimally Invasive
19%
Pancreatic Cancer
19%
Pancreatic Ductal Adenocarcinoma
19%
Regional Analysis
19%
Cancer Resection
19%
Retrospective Cohort Study
19%
Surgical Failure
19%
Trend Analysis
19%
Metastatic Recurrence
19%
Pancreatic Necrosis
19%
Rapid Recurrence
19%
Resection
16%
Length of Stay
15%
Laparoscopy
15%
Gastric Myoelectrical Activity
14%
Direct Endoscopic Necrosectomy
14%
Knock-in Mouse Model
13%
Nodal Positivity
12%
Radiological Response
11%
Skin Wound
8%
Pancreatic Neuroendocrine Tumors (pNETs)
7%
Pancreatectomy
7%
Blood Transfusion
7%
Open Repair
7%
Operative Outcomes
7%
Umbilical Hernia
7%
APACHE II Score
7%
Lesion Patients
6%
MEN1 Gene
6%
Adjuvant Chemotherapy
6%
Cancer Registry
6%
Therapeutic Advances
6%